IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Konadu, E.
Right arrow Articles by Szu, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Konadu, E.
Right arrow Articles by Szu, S. C.

 Previous Article  |  Next Article 

Infection and Immunity, November 1999, p. 6191-6193, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Syntheses and Immunologic Properties of Escherichia coli O157 O-Specific Polysaccharide and Shiga Toxin 1 B Subunit Conjugates in Mice

Edward Konadu,1 Arthur Donohue-Rolfe,2 Stephen B. Calderwood,3 Vince Pozsgay,1 Joseph Shiloach,4 John B. Robbins,1 and Shousun C. Szu1,*

National Institute of Child Health and Human Development1 and National Institute of Diabetes and Digestive and Kidney Diseases,4 National Institutes of Health, Bethesda, Maryland 20892-2720; Tufts University School of Veterinary Medicine, Medford, Massachusetts 015362; and Massachusetts General Hospital, Boston, Massachusetts 021143

Received 18 May 1999/Returned for modification 29 June 1999/Accepted 9 August 1999

Escherichia coli O157 is the major cause of diarrhea-associated hemolytic uremic syndrome (HUS). Strains causing HUS contain either Shiga toxin 1 (Stx1) or Stx2, or both. In adult volunteers, conjugate vaccines of detoxified lipopolysaccharide (LPS) elicited bactericidal antibodies to E. coli O157. Here, the detoxified LPS was conjugated with improved schemes to the nontoxic B subunit of Stx1. Mice injected with these bivalent conjugates elicited both bactericidal antibodies to E. coli O157 and neutralization antibodies to Stx1.

* Corresponding author. Mailing address: National Institute of Child Health and Human Development, Room 424, Building 6, National Institutes of Health, Bethesda, MD 20892-2720. Phone: (301) 496-1185. Fax: (301) 402-9108. E-mail: scszu{at}helix.nih.gov.

Infection and Immunity, November 1999, p. 6191-6193, Vol. 67, No. 11
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 1999 by the American Society for Microbiology. All rights reserved.